Spegra tablets
In stock
Description
Spegra tablet is a fixed-dose combination antiretroviral medication manufactured by Emcure Pharmaceuticals Ltd, designed to treat HIV-1 infection in adults and adolescents (weighing at least 35-40kg). It combines three active ingredients—Dolutegravir (50mg), Emtricitabine (200mg), and Tenofovir Alafenamide (25mg)—into a single, once-daily tablet, enhancing adherence and reducing pill burden.
Specifications
| Main Ingredients | Dolutegravir (50mg), Emtricitabine (200mg), and Tenofovir Alafenamide (25mg) |
|---|---|
| Prescription | Prescription-only medication (Rx) |
| Storage | Store below 30°C, protect from moisture |
| Pack Sizes | 30 Tablets (bottle), 90 Tablets |
| Administration | Oral (daily) |
| Form | Film-coated tablet |
